Hematopoietic and Mesenchymal Stem Cells in Biomedical and Clinical Applications

Affiliations

¹ Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
² Division of Experimental Cancer Research, Department of Laboratory Medicine, Lund University, Malmö, Sweden.
³ Department of Genetics and Bioengineering, T.C. Yeditepe Üniversitesi, Istanbul, Turkey.
⁴ Excellence Cluster Cardio-Pulmonary System, Justus Liebig University, Giessen, Germany.
⁵ CNC-Center for Neuroscience and Cell Biology, UC Biotech Building, University of Coimbra, Cantanhede, Portugal.

Editorial

Albert A Rizvanov et al. Stem Cells Int. 2016.

. 2016:2016:3157365.

doi: 10.1155/2016/3157365. Epub 2016 Nov 24.

¹ Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
² Division of Experimental Cancer Research, Department of Laboratory Medicine, Lund University, Malmö, Sweden.
³ Department of Genetics and Bioengineering, T.C. Yeditepe Üniversitesi, Istanbul, Turkey.
⁴ Excellence Cluster Cardio-Pulmonary System, Justus Liebig University, Giessen, Germany.
⁵ CNC-Center for Neuroscience and Cell Biology, UC Biotech Building, University of Coimbra, Cantanhede, Portugal.

No abstract available

References

1. Lukovic D., Stojkovic M., Moreno-Manzano V., Bhattacharya S. S., Erceg S. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury. Stem Cells and Development. 2014;23(1):1–4. doi: 10.1089/scd.2013.0266. - DOI - PubMed
1. Méndez-Ferrer S., Michurina T. V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829–834. doi: 10.1038/nature09262. - DOI - PMC - PubMed